Lodise, Thomas P.
Tillotson, Glenn S.
Spargo, Andrew
Bozkaya, Duygu
Massey, Jill
Funding for this research was provided by:
cempra pharmaceuticals
Article History
First Online: 10 July 2020
Compliance with Ethical Standards
:
: Melinta Therapeutics, Inc. provided funding for the research for this article.
: TL is a consultant and speaker for Melinta Therapeutics. GST is a consultant for Melinta Therapeutics, and has also received consultant fees from Summit Plc, Spero Therapeutics, Shionogi Inc, and KBP Biosciences. JM is a full-time employee of Melinta Therapeutics. AS and DB have no disclosures.